FrancophonIA/ELRC3.0 huggingface dataset:
English: From these 89 patients, the mean percent reduction in LDL-C was approximately 20%.
Danish: Hos disse patienter var den gennemsnitlige procentvise reduktion i LDL-kolesterol ca. 20%.
English: Atorvastatin was negative for mutagenic and clastogenic potential in a battery of 4 in vitro tests and 1 in vivo assay.
Danish: Atorvastatin viste ikke mutagent eller klastogent potentiale i et batteri af 4 in vitro tests og 1 in vivo undersøgelse.
English: Once a stable prothrombin time has been documented, prothrombin times can be monitored at the intervals usually recommended for patients on coumarin anticoagulants.
Danish: Når der er opnået en stabil protrombintid, kan protrombintiden måles med de intervaller, der normalt anbefales for patienter på coumarin-antikoagulantia.
English: Dose (mg)
Danish: (mg)
English: Common: liver function test abnormal, blood creatine kinase increased.
Danish: Almindelig: Unormale leverfunktionsprøver, forhøjet kreatinkinase i blodet.
English: Patients were treated with either atorvastatin 10 mg daily (n=1,428) or placebo (n=1,410) for a median follow-up of 3.9 years.
Danish: Patienterne blev behandlet med enten atorvastatin 10 mg dagligt (n=1.428) eller placebo (n=1.410) med en middelopfølgningsperiode på 3,9 år.
English: Atorvastatin should be prescribed with caution in patients with pre-disposing factors for rhabdomyolysis.
Danish: Atorvastatin bør gives med forsigtighed til patienter med prædisponerende faktorer for rabdomyolyse.
English: However, lipid effects were greater when {PRODUCT NAME} and colestipol were co-administered than when either medicinal product was given alone.
Danish: Effekten på lipiderne var imidlertid større, når Zarator og colestipol blev indgivet samtidig, end hvis stofferne blev givet hver for sig.
English: Atorvastatin increased mean HDL-C by 2.9% (pravastatin: +5.6%, p=NS).
Danish: Atorvastatin øgede det gennemsnitlige HDLkolesterol med 2,9 % (pravastatin: +5,6 %, p=NS).
English: fold = no change).
Danish: 0% = ingen ændring).
English: This medicinal product is authorised in the Member States of the EEA under the following names: Austria, Bulgaria, Czech Republic, Estonia,
Danish: Dette lægemiddel er godkendt i EEAs medlemslande under følgende navne: Østrig, Bulgarien, Tjekkiet, Estland, Tyskland, Ungarn, Italien, Letland, Litauen, Polen, Rumænien, Slovakiet, Slovenien
English: Potent CYP3A4 inhibitors have been shown to lead to markedly increased concentrations of atorvastatin (see Table 1 and specific information below).
Danish: Potente CYP3A4-hæmmere er vist at kunne medføre kraftigt forøgede koncentrationer af atorvastatin (se tabel 1 samt specifik information nedenfor).
English: Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme responsible for the conversion of 3-hydroxy-3-methyl-glutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol.
Danish: Atorvastatin er en selektiv, kompetitiv hæmmer af HMG-CoA-reduktase, det hastighedsbegrænsende enzym, som er ansvarlig for omdannelsen af 3-hydroxy-3-methyl-glutaryl-coenzym A til mevalonat, et forstadium til steroler, herunder kolesterol.
English: The increased risk was particularly noted in patients with prior hemorrhagic stroke or lacunar infarct at study entry.
Danish: Den øgede risiko blev især noteret hos patienter, der havde hæmoragisk apopleksi i anamnesen eller lakunært infarkt ved forsøgets start.
English: These results are consistent in patients with heterozygous familial hypercholesterolaemia, nonfamilial forms of hypercholesterolaemia, and mixed hyperlipidaemia, including patients with noninsulin-dependent diabetes mellitus.
Danish: Disse resultater er konsistente hos patienter med heterozygot familiær hyperkolesterolæmi, nonfamiliære former for hyperkolesterolæmi og kombineret hyperlipidæmi, herunder patienter med ikke-insulinkrævende diabetes mellitus.
English: Rare: visual disturbance.
Danish: Sjælden: Synsforstyrrelser.
English: The half-life of inhibitory activity for HMG-CoA reductase is approximately 20 to 30 hours due to the contribution of active metabolites.
Danish: Halveringstiden for den hæmmende aktivitet over for HMG-CoA-reduktase er ca. 20-30 timer på grund af aktive metabolitter.
English: 1Based on difference in crude events rates occurring over a median follow-up of 3.3 years.
Danish: 1På baggrund af forskelle i det samlede antal hændelser opstået over en middelopfølgningsperiode på 3,3 år
English: {PRODUCT NAME} should be used with caution in patients who consume substantial quantities of alcohol and/or have a history of liver disease.
Danish: Zarator bør bruges med forsigtighed hos patienter, som indtager store mængder alkohol og/eller med leversygdom i anamnesen.
English: Interaction studies evaluating the effects of amiodarone or verapamil on atorvastatin have not been conducted.
Danish: Der er ikke udført interaktionsstudier, der vurderes virkningen af amiodaron eller verapamil på atorvastatin.
English: Atorvastatin was not found to be carcinogenic in rats, but high doses in mice (resulting in 6-11 fold the AUC0-24h reached in humans at the highest recommended dose) showed hepatocellular adenomas in males and hepatocellular carcinomas in females.
Danish: Atorvastatin var ikke karcinogent hos rotter, men høje doser hos mus (resulterende i en 6-11 gange så høj AUC0-24t, som der ses hos mennesker ved maksimale doser) viste hepatocellulære adenomer.hos hanner og hepatocellulære karcinomer hos hunner.
English: Before starting treatment, your doctor will place you on a low-cholesterol diet, which you should maintain also during therapy with {PRODUCT NAME}.
Danish: Før De starter behandling, vil Deres læge sætte Dem på en kolesterolfattig diæt, som De skal fortsætte med under behandlingen med Zarator.
English: Atorvastatin is metabolized by cytochrome P450 3A4 to ortho- and parahydroxylated derivatives and various beta-oxidation products.
Danish: Atorvastatin metaboliseres via cytokrom P450 3A4 til orto- og parahydroxylerede derivater og forskellige beta-oxidationsprodukter.
English: Rare reports of congenital anomalies following intrauterine exposure to HMG-CoA reductase inhibitors have been received.
Danish: Sjældne rapporter om medfødte anomalier efter intrauterin påvirkning af HMG-CoAreduktasehæmmere er set.
English: Rare: angioneurotic oedema, dermatitis bullous including erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Danish: Sjælden: Angioødem, bulløs dermatitis (herunder erythema multiforme, Stevens-Johnsons syndrom og toksisk epidermal nekrolyse).
English: 40 mg on day 1, 10 mg on day 20
Danish: 40 mg på dag 1, 10 mg på dag 20
English: Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites.
Danish: Ca. 70 % af hæmningen af HMG-CoA-reduktase tilskrives aktive metabolitter.
English: The dose of atorvastatin in patients with homozygous familial hypercholesterolemia is 10 to 80 mg daily (see section 5.1).
Danish: Dosis af atorvastatin til patienter med homozygot familiær hyperkolesterolæmi er 10-80 mg dagligt (se pkt.
English: Due to the dual interaction mechanism of rifampin, (cytochrome P450 3A induction and inhibition of hepatocyte uptake transporter OATP1B1), simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations.
Danish: På grund af rifampicins dualinteraktionsmekanisme (cytochrom P450 3A-induktion og hæmning af transportproteinet OATP1B1 i leveren) anbefales indtagelse af atorvastatin og rifampicin på samme tid, da udskudt administration af atorvastatin i forhold til administration af rifampicin været forbundet med en signifikant reduktion i atorvastatins plasmakoncentration.
English: {PRODUCT NAME} belongs to a group of medicines known as statins, which are lipid (fat) regulating medicines.
Danish: Zarator tilhører en gruppe lægemidler, som kaldes statiner, og som er kolesterolsænkende medicin.
English: {PRODUCT NAME} is for oral administration.
Danish: Zarator er til oral anvendelse.
English: If concomitant administration cannot be avoided, a dose reduction and clinical monitoring for efficacy is recommended (see Table 1).
Danish: Hvis samtidig behandling ikke kan undgås, anbefales dosisreduktion og klinisk monitorering for effekt (se tabel 1).
English: The maximum dose is 80 mg once a day.
Danish: Den maksimale dosis er 80 mg én gang dagligt.
English: Total mortality and cardiovascular mortality were not significantly reduced (185 vs. 212 events, p=0.17 and 74 vs. 82 events, p=0.51).
Danish: Den totale mortalitet og den kardiovaskulære mortalitet blev ikke signifikant nedsat (185 vs. 212 hændelser; p=0,17 og 74 vs. 82 hændelser; p=0,51).
English: In the MIRACL study, atorvastatin 80 mg has been evaluated in 3,086 patients (atorvastatin n=1,538; placebo n=1,548) with an acute coronary syndrome (non Q-wave MI or unstable angina).
Danish: I MIRACL-studiet blev atorvastatin 80 mg vurderet hos 3.086 patienter (atorvastatin n=1.538; placebo n=1.548) med akut koronarsyndrom (non-Q-tak MI eller ustabil angina).
English: Transport protein inhibitors
Danish: Transportprotein-hæmmere
English: Infections and infestations: Common: nasopharyngitis.
Danish: Infektioner og parasitære sygdomme Almindelig: Nasopharyngitis.
English: As with other HMG-CoA reductase inhibitors elevated serum transaminases have been reported in patients receiving {PRODUCT NAME}.
Danish: Som for andre HMG-CoA-reduktasehæmmere er der blevet rapporteret om forhøjede serum-transaminaser hos patienter, der behandles med Zarator.
English: Treatment with atorvastatin 80 mg/day increased the time to occurrence of the combined primary endpoint, defined as death from any cause, nonfatal MI, resuscitated cardiac arrest, or angina pectoris with evidence of myocardial ischaemia requiring hospitalization, indicating a risk reduction by 16% (p=0.048).
Danish: Behandling med 80 mg atorvastatin dagligt forlængede tiden til forekomst af det kombinerede primære endepunkt, defineret som død af enhver årsag, ikke-letalt MI, genoplivet efter hjertestop eller angina pectoris med tegn på myokardieiskæmi, der kræver hospitalsindlæggelse, og indikerede en risikoreduktion på 16 % (p=0,048).
English: Major cardiovascular events (fatal and non-fatal AMI, silent MI, acute CHD death, unstable angina, CABG, PTCA, revascularization, stroke) MI (fatal and non-fatal AMI, silent MI)
Danish: Større kardiovaskulære hændelser (letalt og ikke-letalt AMI, tavst MI, akut, dødelig CHD, ustabil angina, CABG, PTCA, revaskularisering, apopleksi)
English: Blood and lymphatic system disorders Rare: thrombocytopenia.
Danish: Blod- og lymfesystem Sjælden: Trombocytopeni.
English: − If symptoms resolve and CK levels return to normal, then re-introduction of atorvastatin or introduction of an alternative statin may be considered at the lowest dose and with close monitoring.
Danish: Hvis symptomerne forsvinder, og CK-værdien normaliseres, bør re-introduktion af atorvastatin eller introduktion af anden statinbehandling overvejes, idet der gives laveste dosis og monitores tæt.
English: Antacid suspension of magnesium and aluminium hydroxides, 30 mL QID, 2 weeks
Danish: Antacida (suspension med magnesium- og aluminiumhydroxid, 30 ml x 4, 2 uger
English: • Exceptional cases of interstitial lung disease, especially with long term therapy (see section 4.4).
Danish: • Sjældne tilfælde af interstitiel lungesygdom, særligt ved langtidsbrug (se pkt.
English: Patients were hypertensive, 40-79 years of age, with no previous myocardial infarction or treatment for angina, and with TC levels ≤6.5 mmol/l (251 mg/dl).
Danish: Patienterne var hypertensive, i alderen 40-79 år, uden tidligere myokardieinfarkt eller behandling for angina og havde total-kolesterol på 6,5 mmol/l (251 mg/dl).
English: Patients were treated with anti-hypertensive therapy (either amlodipine or atenolol-based regimen) and either atorvastatin 10 mg daily (n=5,168) or placebo (n=5,137).
Danish: Patienterne fik antihypertensiv behandling (enten amlodipin- eller atenolol-baseret regime) og enten atorvastatin 10 mg dagligt (n=5.168) eller placebo (n=5.137).
English: The development of the rat offspring was delayed and post-natal survival reduced during exposure of the dams to high doses of atorvastatin.
Danish: Rotteafkom udviste forsinket udvikling, og den post-natal overlevelse var lavere, hvis moderdyrene havde været udsat for høje doser atorvastatin.
English: • anorexia (loss of appetite), weight gain, decreases in blood sugar levels (if you have diabetes you should continue careful monitoring of your blood sugar levels)
Danish: • appetitmangel, vægtøgning, lavt blodsukkerniveau (hvis De har diabetes, skal De kontrollere blodsukkerniveauet omhyggeligt)
English: Adjustment of dose should be made at intervals of 4 weeks or more.
Danish: Dosis skal justeres med intervaller på 4 uger eller mere.
English: Important information about some of the ingredients of {PRODUCT NAME} If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Danish: Vigtig information om nogle af de øvrige indholdsstoffer i Zarator Kontakt lægen, før De tager denne medicin, hvis lægen har fortalt dem, at De ikke tåler visse sukkerarter.
English: Atorvastatin should be used as an adjunct to other lipid-lowering treatments (e.g. LDL apheresis) in these patients or if such treatments are unavailable.
Danish: Atorvastatin skal gives som supplement til anden lipidsænkende behandling (f.eks. LDL-aferese), eller hvis sådan behandling ikke er tilgængelig.
English: If CK levels are significantly elevated (> 5 times ULN) at baseline, treatment should not be started.
Danish: Hvis CK-værdien er signifikant forhøjet (>5 gange den øvre referenceværdi) ved baseline, bør behandlingen ikke startes.
English: The mean LDL-C was 73 mg/dL (1.9 mmol/L) during treatment with atorvastatin and 129 mg/dL (3.3 mmol/L) during treatment with placebo.
Danish: Det gennemsnitlige LDL-kolesterol var 1,9 mmol/l (73 mg/dl) under behandling med atorvastatin og 3,3 mmol/l (129 mg/dl) under behandling med placebo.
English: • blood test results that show your liver function can become abnormal
Danish: • blodprøveresultater, der tyder på unormal leverfunktion
English: Do not take {PRODUCT NAME} if you are pregnant, or if you are trying to become pregnant.
Danish: De må ikke tage Zarator, hvis De er gravid, eller hvis De ønsker at blive gravid.
English: Elevated serum creatine kinase (CK) levels greater than 3 times upper limit of normal occurred in 2.5% of patients on {PRODUCT NAME}, similar to other HMG-CoA reductase inhibitors in clinical trials.
Danish: Forhøjet serum-kreatinkinase (CK)-niveau på mere end 3 gange den øvre referenceværdi er set hos 2,5 % af de patienter, som behandles med Zarator, hvilket svarer til andre HMG-CoA-reduktasehæmmere i kliniske studier.
English: Concomitant administration of medicinal products that are inhibitors of CYP3A4 or transport proteins may lead to increased plasma concentrations of atorvastatin and an increased risk of myopathy.
Danish: Samtidig indgift af lægemidler, der hæmmer CYP3A4 eller transportproteiner, kan medføre forhøjede plasmakoncentrationer af atorvastatin og øget risiko for myopati.
English: SLOC1B1 polymorphism: Hepatic uptake of all HMG-CoA reductase inhibitors including atorvastatin, involves the OATP1B1 transporter.
Danish: SLCO1B1-polymorfisme: Hepatisk optagelse af alle HMG-CoA-reduktasehæmmere, herunder atorvastatin, involverer OATP1B1-transportproteinet.
English: Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.
Danish: Atorvastatin sænker plasma-kolesterol- og serum-lipoprotein-koncentrationen ved at hæmme HMG-CoAreduktase og som følge deraf kolesterolbiosyntesen i leveren og øger antallet af hepatiske LDL-receptorer på celleoverfladen, hvilket fører til øget optagelse og katabolisering af LDL.
English: • visual disturbance
Danish: • synsforstyrrelser
English: Plasma concentrations of atorvastatin and its active metabolites were lower (by approx. 25%) when colestipol was co-administered with {PRODUCT NAME}.
Danish: Plasmakoncentrationerne af atorvastatin og dets aktive metabolitter var lavere (ca. 25 %), når colestipol blev indgivet sammen med Zarator.
English: In patients with SLCO1B1 polymorphism there is a risk of increased exposure of atorvastatin, which may lead to an increased risk of rhabdomyolysis (see section 4.4).
Danish: Hos patienter med SLCO1B1-polymorfisme er der en risiko for forhøjede koncentrationer af atorvastatin, der kan medføre en øget risiko for rabdomyolyse (se pkt.
English: The recommended starting dose in this population is 10 mg of atorvastatin per day.
Danish: Den anbefalede startdosis til denne gruppe er 10 mg atorvastatin dagligt.
English: For patients with prior hemorrhagic stroke or lacunar infarct, the balance of risks and benefits of atorvastatin 80 mg is uncertain, and the potential risk of hemorrhagic stroke should be carefully considered before initiating treatment (see section 5.1).
Danish: Hos patienter med hæmoragisk apopleksi eller lakunært infarkt i anamnesen var risiko/benefit ratio for atorvastatin 80 mg usikker, og den potentielle risiko for hæmoragisk apopleksi skal omhyggeligt overvejes før initiering af behandling (se pkt.
English: In the atorvastatin placebo-controlled clinical trial database of 16,066 (8755 Lipitor vs. 7311 placebo) patients treated for a mean period of 53 weeks, 5.2% of patients on atorvastatin discontinued due to adverse reactions compared to 4.0% of the patients on placebo.
Danish: Ifølge databasen over placebo-kontrollerede kliniske forsøg med atorvastatin hos 16.066 patienter (8.755 fik Zarator og 7.311 placebo), der blev behandlet i gennemsnitligt 53 uger, seponerede 5,2% af de patienter, der fik atorvastatin, behandligen pga. bivirkninger sammenlignet med 4,0% af de patienter, der fik placebo.
English: If these levels are found to be significantly elevated (> 5 times ULN), treatment should be stopped.
Danish: Hvis denne værdi er signifikant forhøjet (>5 gange den øvre referenceværdi), bør behandlingen stoppes.
English: The risk of myopathy may also be increased with the concomitant use of gemfibrozil and other fibric acid derivates, erythromycin, niacin and ezetimibe.
Danish: Risikoen for myopati kan også øges ved samtidig administration af gemfibrozil og andre fibrater, erythromycin, niacin og ezetimibe.
English: Animal studies have shown toxicity to reproduction (see section 5.3).
Danish: Dyreforsøg har vist reproduktionstoksicitet (se pkt.
English: Women of child-bearing potential should use appropriate contraceptive measures during treatment (see section 4.3).
Danish: Kvinder i den fertile alder skal anvende sikker kontraception under behandlingen (se pkt.
English: There was a 36.4% mean reduction in CRP in the atorvastatin group compared to a 5.2% reduction in the pravastatin group (p<0.0001).
Danish: Der var 36,4 % gennemsnitsreduktion i C-reaktivt protein (CRP) i atorvastatingruppen sammenlignet med 5,2 % reduktion i pravastatingruppen (p<0,0001).
English: Data given as % change represent % difference relative to atorvastatin alone (i.e., 0% = no change).
Danish: Data angivet som procentvis ændring angiver procentvis forskel i forhold til atorvastatin alene (dvs. 0% = ingen ændring).
English: Possible side effects reported with some statins (medicines of the same type):
Danish: Følgende bivirkninger er set ved behandling med nogle statiner (medicin af samme type som Zarator):
English: Atorvastatin, like other HMG-CoA reductase inhibitors, may in rare occasions affect the skeletal muscle and cause myalgia, myositis, and myopathy that may progress to rhabdomyolysis, a potentially lifethreatening condition characterised by markedly elevated creatine kinase (CK) levels (> 10 times ULN), myoglobinaemia and myoglobinuria which may lead to renal failure.
Danish: Atorvastatin kan som andre HMG-CoA-reduktasehæmmere i sjældne tilfælde påvirke skeletmuskulaturen og forårsage myalgi, myositis og myopati, som kan udvikle sig til rabdomyolyse en potentielt livstruende tilstand, som kendetegnes ved markant forhøjet kreatinkinase (CK)-værdi (>10 gange den øvre referenceværdi), myoglobinæmi og myoglobinuri, som kan medføre nyresvigt.
English: When compared to pravastatin the effects of atorvastatin were statistically significant (p=0.02).
Danish: Effekten af atorvastatin er statistisk signifikant (p=0,02) ved sammenligning med pravastatin.
English: Relative Risk Reduction
Danish: Relativ risikoreduktion (%)
English: [See Annex I - To be completed nationally]
Danish: [Se Bilag I - udfyldes nationalt]
English: Event
Danish: Hændelse
English: Patients who develop increased transaminase levels should be monitored until the abnormality(ies) resolve.
Danish: Patienter, som får forhøjede transaminaseniveauer, skal monitoreres, indtil tallene er normaliserede.
English: − The active substance is atorvastatin.
Danish: Aktivt stof: atorvastatin.
English: It is possible that the net risk of stroke is increased in patients with prior lacunar infarct who receive atorvastatin 80 mg/day.
Danish: Det er muligt, at den absolutte risiko for apopleksi er øget hos patienter med tidligere lakunært infarkt, som får 80 mg atorvastatin dagligt.
English: Saquinavir 400 mg BID/ Ritonavir (300 mg BID from days 5-7, increased to 400 mg BID on day 8), days 5-18, 30 min after atorvastatin dosing
Danish: Saquinavir 400 mg x 2/ Ritonavir (300 mg x 2 fra dag 5-7, øget til 400 mg x 2 på dag 8), dag 5-18, 30 minutter efter atorvastatindosis
English: In vitro, inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of atorvastatin.
Danish: In vitro hæmmer ortho- og parahydroxylerede metabolitter HMG-CoA-reduktase i samme grad som atorvastatin.
English: Levels above 10 times the normal upper range occurred in 0.4% {PRODUCT NAME}-treated patients (see section 4.4).
Danish: Niveauer på mere end 10 gange den øvre referenceværdi er set hos 0,4 % af de Zarator-behandlede patienter (se pkt.
English: Presenting features can include dyspnoea, non-productive cough and deterioration in general health (fatigue, weight loss and fever).
Danish: Symptomer kan inkludere dyspnø, tør hoste og forværring af den almindelige helbredstilstand (træthed, vægttab og feber).
English: However, atorvastatin does not appear to undergo significant enterohepatic recirculation.
Danish: Lægemidlet undergår imidlertid ikke signifikant enterohepatisk recirkulation.
English: In the Reversing Atherosclerosis with Aggressive Lipid- Lowering Study (REVERSAL), the effect of intensive lipid lowering with atorvastatin 80 mg and standard degree of lipid lowering with pravastatin 40 mg on coronary atherosclerosis was assessed by intravascular ultrasound (IVUS), during angiography, in patients with coronary heart disease.
Danish: I ”Reversing Atherosclerosis with Aggressive Lipid-Lovering Study” (REVERSAL) blev effekten af intensiv lipidsænkning med atorvastatin 80 mg og standard-lipidsænkning med pravastatin 40 mg på koronar aterosklerose vurderet ved hjælp af intravaskulær ultralyd (IVUS) under angiografi hos patienter med koronar hjertesygdom.
English: Skin rash with pink-red blotches especially on palms of hands or soles of feet which may blister.
Danish: Hududslæt med lyserøde-røde pletter eller blærer, især på håndflader og fodsåler.
English: Each daily dose of atorvastatin is given all at once and may be given at any time of day with or without food.
Danish: Dosis kan gives på et hvilket som helst tidspunkt af døgnet med eller uden føde.
English: Interaction studies with atorvastatin and fusidic acid have not been conducted.
Danish: Der er ikke udført interaktionsstudier med atorvastatin og fusidinsyre.